Skip to content
Current 94.3
    • Homepage
Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Author: Whitehawk Therapeutics, Inc.

Posted Date:

August 6, 2026
  • Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

    Whitehawk Therapeutics, Inc.
    August 6, 2026
  • Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026

    Whitehawk Therapeutics, Inc.
    May 30, 2026
  • Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference

    Whitehawk Therapeutics, Inc.
    May 28, 2026